Kari Pitkänen

[Johanna Arola @JohannaArola]

Hieno homma tarjolla ⁦@helsinkiuni⁩ https://t.co/3RWGDOi2FG

[Eemeli @LosBrolin]

cycling hooligans on course, vibe is very international

[Aiforia @aiforia_tech]

Interested in AI models and the various fields they can be used in? Over 400 AI models have been made with Aiforia Create so far in a huge range of applications! Explore our use cases here: https://t.co/T6J1FYtPuj

[Aiforia @aiforia_tech]

Tune in to our talk at @EACR today! Hear from pathologists Dr. Mirtti and Dr. Sandeman presenting on creating an AI model for prostate #cancer grading and its potential to transform clinical #pathology and cancer #diagnostics. Find out more here: https://t.co/MJMkxmtdci

[Aiforia @aiforia_tech]

We are excited to announce that Aiforia has raised €12.6M in series B funding! Led by Epredia’s UK entity, the fresh funding will help strengthen our portfolio of AI-powered pathology tools for clinical diagnostics and preclinical analysis. https://t.co/gYLCDsVzFI

[Aiforia @aiforia_tech]

Parkinson’s disease (PD) is a neurological disorder affecting up to 10 million people worldwide. Read about how predoctoral researcher Joan Compte is cutting down his PD cell counting from months to minutes through AI based image analysis: https://t.co/mMvgB7eVgL

[Aiforia @aiforia_tech]

We are presenting on AI-assisted diagnostics at the #ECDP virtual symposium next week! Tune in to find out about practical, ease-of-use AI solutions in the pathology lab! Can't attend? Find out more about AI-driven diagnostics with this case study video: https://t.co/UnpNFuj12S

[Aiforia @aiforia_tech]

We are thrilled to announce the CE-IVD mark of the Aiforia™ Clinical AI Model for Breast Cancer: Ki67. Find out why the Aiforia Ki67 AI Model is a first-of-its kind diagnostic tool for pathologists to harness the full potential of their own expertise: https://t.co/jJDNCk5sWm

[Aiforia @aiforia_tech]

We recently interviewed pathologists from two different hospitals on their experiences and thoughts about the benefits of AI to the digitized clinical workflow, its impact on pathologists' productivity, cancer diagnostics and more! https://t.co/PDFzLrnS6u

[Aiforia @aiforia_tech]

Join Dr. Mark Smith Veterinary Pathologist at @CRiverLabs, presenting his recent publication with Aiforia's Dr. Thomas Westerling-Bui (@TWesterling_Bui), who will also give a quick, live demo of the Aiforia AI for image analysis software used!

Register: https://t.co/6mQuVC8ucL

[Kaisa Helminen @kaisa_helminen]

Excited to share the news about @aiforia_tech and @XZELLInc partnership!

[Aiforia @aiforia_tech]

NEWS! We have partnered with med-tech company @XZELLInc to build a novel, AI-powered method for early cancer detection.

Find out more: https://t.co/RhRBh4A7Fj

[Aiforia @aiforia_tech]

We are at the Experimental Biology @expbio conference today! Explore our latest case studies and solutions for increasing the speed and accuracy of image analysis across a huge range of areas in pathology! Direct link to our booth for #ExpBio attendees: https://t.co/8cUzHRVDv3

[Aiforia @aiforia_tech]

We are hiring! The Aiforia science team is looking for an ambitious Project Manager for our clinical product development. Are you ready to help us transform clinical diagnostics with the power of AI? Apply now: https://t.co/l4Annr5206
#hiring #projectmanager #clinicaldiagnostics

[Aiforia @aiforia_tech]

We interviewed Dr. Jose Lanciego, Director of a neuroanatomy lab in Pamplona, Spain, on his research team’s experience of using Aiforia Create to advance their understanding of the pathophysiology involved in neurodegenerative diseases such as Parkinson’s. https://t.co/zyeX9uMonY

[Aiforia @aiforia_tech]

Interested in AI and how it's changing the world of pathology? Sign up for our AI Bulletin and we'll share with you all that our experts know. Biweekly emails with guides, articles, and case studies: https://t.co/W7LJ6VAQKV

[Aiforia @aiforia_tech]

Explore our latest infographic, a case study with Boehringer Ingelheim Pharmaceuticals on developing an AI-based quantitation of DSS colitis: https://t.co/aTkHqNPn8q

[Veera Rajagopal  @doctorveera]

This paper by Mars et al is the most compelling paper that I read in this theme. The authors show that, in mutation carriers, PRS modifies breast cancer risk to the point that carriers with low PRS have lesser risk even than the general population.
https://t.co/ATfmWFj0W4

[Aiforia @aiforia_tech]

Join our star studded virtual event with speakers from @MayoClinic, @Boehringer, and @QuantumCyte to hear about AI powered analysis in preclinical studies, oncology, and molecular pathology. Sign up for our free event now: https://t.co/2v2iRXNZFT

[Kaisa Helminen @kaisa_helminen]

Congrats Lauren Prince!! @aiforia_tech @CRiverLabs